Brazil’s public health system will begin offering fecal immunochemical tests (FIT) for colorectal cancer screening in December, seven months after the Health Ministry announced the program, Estadão reported.
The initial rollout will provide only 400 mil test kits for a target population of 51 million Brazilians aged 50 to 75, according to Flávia Kelli Alvarenga Pinto, adjunct director of the ministry’s Cancer Care Department. Distribution is limited to state capitals and municipalities with more than 500 mil residents where colonoscopy capacity exists to follow up positive results.
“It doesn’t help to implement screening in a place that won’t have the capacity to follow up on the patient,” Pinto said during the Brazilian Society of Clinical Oncology congress on Nov. 7. States retain autonomy to allocate kits elsewhere, she told Estadão. The FIT detects microscopic blood in stool with 85% to 92% accuracy and requires no bowel preparation, unlike colonoscopy, which remains the diagnostic gold standard for identifying polyps and precursor lesions, according to Estadão. A positive FIT result triggers a colonoscopy referral; a negative result calls for retesting in two years.
The test is intended for asymptomatic individuals; anyone with symptoms such as visible blood in stool, abdominal pain, unexplained weight loss, or changed bowel habits should seek medical evaluation directly. Brazil’s starting age of 50 contrasts with the United States, where the American Cancer Society lowered the recommended screening age to 45 in 2018 amid rising incidence in younger adults, Correio do Povo noted. The Brazilian Society of Coloproctology also recommends routine colonoscopy from age 45.
Samuel Aguiar Jr., leader of the Colorectal Tumor Reference Center at A.C.Camargo Cancer Center, said the ministry’s age threshold balances disease incidence in each age group against the health system’s capacity to deliver exams. “It’s a balance between use of public resources and lives saved,” Aguiar told UOL. “You want to save the greatest number of lives possible within the resources you have available.”
Danilo Munhóz, a coloproctologist at Clínica Primazo and the Brazilian Society of Coloproctology, told UOL that expanding screening to younger ages would swell the pool of asymptomatic patients referred for colonoscopy. “Screening from 50 upward is already a challenge in a country like Brazil. We already have huge waiting lines, sometimes even in the private sector, waiting for colonoscopies,” he said.
Giovanni Luigi, vice president of the Brazilian Gastric Cancer Association’s southern region, attributed rising youth cases to dietary shifts toward ultra-processed foods and warned that younger patients often delay investigation because they fall outside screening guidelines.
“The problem of the young patient is that he won’t get a colonoscopy,” Luigi told Correio do Povo. The ministry said the initial shipment criteria weigh epidemiological data, colonoscopy availability, and the network’s ability to guarantee diagnosis and treatment.
SUS, created by Federal Law 8.080 on 19 September 1990 after the 1988 Constitution established health as a universal right, is the world’s largest government-run public health system by beneficiaries — virtually all of Brazil’s 220 million people — land area (8.5 million km²), and affiliated treatment centers (over 50,000 clinics). Before SUS, only formal social-security contributors could access public care, leaving more than 80% of the population dependent on the new system for medical treatment.
Background on incidence and earlier policy steps
Colorectal cancer is the third most prevalent neoplasia in Brazil, with about 45 thousand new cases per year according to the National Cancer Institute (INCA), and the second leading cause of cancer death behind lung cancer. In 2025, roughly 27 thousand Brazilians died from the disease. Cancer that killed singer Preta Gil in 2025, at age 50, and actress Lua Blanco this year, at age 39, has drawn public attention to rising incidence among younger adults.
The Health Ministry and INCA had been pressed by medical and scientific societies to adopt a screening protocol given the increase in cases among younger people.
In August, the ministry announced that the Fecal Immunochemical Test (FIT) had been added to the SUS procedure table for colorectal cancer screening, a step the ministry said could expand prevention access to more than 40 million Brazilians. The Brazilian prevention campaign is led by the Brazilian Society of Digestive Endoscopy, the Brazilian Federation of Gastroenterology, and the Brazilian Society of Coloproctology.
Worth a look